- Filed
- Nov 5, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Oct 31, 2021 | 33.15M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 32.15M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 32.32M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 28.67M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 28.68M sh |
| Stock Repurchased | Q3 2021 · Sep 30, 2021 | $2.03M |
| Stock Repurchased | Q3 2021 · Sep 30, 2020 | $3.23M |
| Capex | Q3 2021 · Sep 30, 2021 | $6.36M |
| Capex | Q3 2021 · Sep 30, 2020 | $3.72M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | $81.36M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | $64.22M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $814.04M |
| Stockholders Equity | Q3 2021 · Jun 30, 2021 | $794.57M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $757.15M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | $643.2M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | $632.83M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $621.28M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $11.34B |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $9.14B |
| Total Assets | Q3 2021 · Sep 30, 2021 | $12.16B |
| Total Assets | Q3 2021 · Dec 31, 2020 | $9.9B |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $0.44 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $1.20 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.26 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.93 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $0.46 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $1.24 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.26 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.95 |
| Net Income | Q3 2021 · Sep 30, 2021 | $20.02M |
| Net Income | Q3 2021 · Sep 30, 2021 | $55M |
| Net Income | Q3 2021 · Sep 30, 2020 | $9.33M |
| Net Income | Q3 2021 · Sep 30, 2020 | $32.62M |